Magnetic bead-sensitized optoporation coupled with antibodies-based activation for mRNA CAR-T cell manufacturing
Immunotherapy is facing a revolution with the advent of immune cell engineering.Chimeric antigen receptor (CAR)-T cell therapy has shown unprecedented efficacy in B cell malignancies and is now being evaluated in other disease areas.Viral transduction is the most common method for immune cell genetic engineering, but presents important limitations,